Sino Biopharmaceutical Limited (HKG:1177)
Hong Kong · Delayed Price · Currency is HKD 6.17
+0.04 (0.65%)
At close: Mar 9, 2026
Sino Biopharmaceutical Market Cap
Sino Biopharmaceutical has a market cap or net worth of 110.3 billion as of March 9, 2026. Its market cap has increased by 87.79% in one year.
Market Cap
110.30B
Enterprise Value
115.27B
Revenue
33.49B
Ranking
n/a
PE Ratio
26.15
Stock Price
6.17
Market Cap Chart
Since September 29, 2000, Sino Biopharmaceutical's market cap has increased from 329.97M to 110.30B, an increase of 33,326.76%. That is a compound annual growth rate of 25.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 110.30B | -0.16% |
| Dec 31, 2025 | 110.48B | 89.64% |
| Dec 31, 2024 | 58.26B | -8.75% |
| Dec 29, 2023 | 63.85B | -24.41% |
| Dec 30, 2022 | 84.46B | -17.53% |
| Dec 31, 2021 | 102.41B | -27.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 261.29B |
| WuXi Biologics | 150.36B |
| Innovent Biologics | 144.54B |
| Akeso | 98.84B |
| Sichuan Kelun-Biotech Biopharmaceutical | 90.06B |
| RemeGen | 59.85B |
| 3SBio | 53.95B |
| Shanghai Henlius Biotech | 37.50B |